National Institute of Arthritis and Musculoskeletal and Skin Diseases

NCT07428746

CollaboratorPhase 3Recruiting202620 people24 Feb 2026clinicaltrials.gov

NCT06674109

CollaboratorPhase 4Recruiting202660 people5 Nov 2024clinicaltrials.gov

NCT06558188

CollaboratorPhase 4Recruiting202550 people16 Aug 2024clinicaltrials.gov

NCT05900466

CollaboratorPhase 2Recruiting202372 people12 Jun 2023clinicaltrials.gov

NCT04875702

CollaboratorPhase 4Recruiting2024650 people6 May 2021clinicaltrials.gov

NCT04815902

CollaboratorPhase 1/2Status unknown2021100 people25 Mar 2021clinicaltrials.gov

NCT04026256

CollaboratorPhase 4Completed201937 people19 Jul 2019clinicaltrials.gov

NCT03360916

CollaboratorPhase 4Completed201852 people4 Dec 2017clinicaltrials.gov

NCT03351998

CollaboratorPhase 4Completed201868 people24 Nov 2017clinicaltrials.gov

NCT02939573

CollaboratorPhase 2Recruiting201790 people20 Oct 2016clinicaltrials.gov

NCT02370784

CollaboratorPhase 2Completed201524 people25 Feb 2015clinicaltrials.gov

NCT02091219

CollaboratorEarly phase 1Completed201435 people19 Mar 2014clinicaltrials.gov

NCT01794117

Phase 2Completed201318 people18 Feb 2013clinicaltrials.gov

NCT01694433

CollaboratorPhase 2/3Completed201366 people27 Sept 2012clinicaltrials.gov

NCT01441076

Phase 1/2Completed20116 people27 Sept 2011clinicaltrials.gov

NCT01153425

CollaboratorPhase 4Completed200833 people30 Jun 2010clinicaltrials.gov

NCT01038323

CollaboratorPhase 4Completed200958 people23 Dec 2009clinicaltrials.gov

NCT01032993

CollaboratorPhase 2/3Completed200968 people16 Dec 2009clinicaltrials.gov

NCT00891696

CollaboratorPhase 1Completed2009144 people1 May 2009clinicaltrials.gov

NCT00668941

CollaboratorPhase 2Status unknown2005140 people29 Apr 2008clinicaltrials.gov

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Y01FY2024 NHANES DXA Osteoporosis Assessment Component/StudyAR24001001-US$1mreporter.nih.gov

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Y01FY2024 NHANES DXA Osteoporosis Assessment Component/StudyAR24001001-US$1mreporter.nih.gov

Mary L Bouxsein

R21An Oleoyl Serine Derivative as an Innovative Therapeutic Approach for OsteoporosisR21AR0886022026–202817 Sept 2026reporter.nih.gov

Roland E Baron

R21An Oleoyl Serine Derivative as an Innovative Therapeutic Approach for OsteoporosisR21AR0886022026–202817 Sept 2026reporter.nih.gov

Beth Israel Deaconess Medical Center

R21An Oleoyl Serine Derivative as an Innovative Therapeutic Approach for OsteoporosisR21AR088602US$430.8k2026–202817 Sept 2026reporter.nih.gov

Sade W Clayton

K99The Role of CD3+ T Lymphocytes in Intervertebral Disc Repair and AgingK99AR0882052026–202817 Sept 2026reporter.nih.gov

Washington University

K99The Role of CD3+ T Lymphocytes in Intervertebral Disc Repair and AgingK99AR088205US$115.3k2026–202817 Sept 2026reporter.nih.gov

Honey Hendesi

R01Intermittent Fasting Enhances Fracture Healing in Obesity via Gut Microbiome ModulationR01AR0882152026–203017 Sept 2026reporter.nih.gov

University of Colorado, Denver

R01Intermittent Fasting Enhances Fracture Healing in Obesity via Gut Microbiome ModulationR01AR088215US$534.5k2026–203017 Sept 2026reporter.nih.gov

Pooja Flora

R00Identifying epigenetic factors in control of epidermal stem cell longevity in the adult skinR00AR0829562025–202817 Sept 2026reporter.nih.gov

University of California, Riverside

R00Identifying epigenetic factors in control of epidermal stem cell longevity in the adult skinR00AR082956US$231k2025–202817 Sept 2026reporter.nih.gov

Michelle Szu-Huei Yau

R56Identifying pre-osteoarthritis endotypes and mechanismsR56AR0753562026–202717 Sept 2026reporter.nih.gov

Hebrew Rehabilitation Center for Aged

R56Identifying pre-osteoarthritis endotypes and mechanismsR56AR075356US$604.4k2026–202717 Sept 2026reporter.nih.gov

Lisa Reider

UG3Dual Implant vs. Single Implant for Distal End of Femur (DISIDE) TrialUG3AR0871122026–202717 Sept 2026reporter.nih.gov

Justin Haller

UG3Dual Implant vs. Single Implant for Distal End of Femur (DISIDE) TrialUG3AR0871122026–202717 Sept 2026reporter.nih.gov

University of Utah

UG3Dual Implant vs. Single Implant for Distal End of Femur (DISIDE) TrialUG3AR087112US$344.3k2026–202717 Sept 2026reporter.nih.gov

Lilian Irene Plotkin

R01Fmr1 and the regulation of osteoblast to osteocyte differentiation and bone mass and strengthR01AR0865972026–203117 Sept 2026reporter.nih.gov

Indiana University Indianapolis

R01Fmr1 and the regulation of osteoblast to osteocyte differentiation and bone mass and strengthR01AR086597US$452.9k2026–203117 Sept 2026reporter.nih.gov

John Martin

R01Deciphering Disc Degeneration: Untangling the Roles of Age and InflammationR01AR0851372025–203016 Sept 2026reporter.nih.gov

Chun-Yuh Huang

R01Deciphering Disc Degeneration: Untangling the Roles of Age and InflammationR01AR0851372025–203016 Sept 2026reporter.nih.gov

University of Miami Coral Gables

R01Deciphering Disc Degeneration: Untangling the Roles of Age and InflammationR01AR085137US$587k2025–203016 Sept 2026reporter.nih.gov

Comparison of lumbar paraspinal muscle size and density between members of the US Framingham Heart Study and Tsimane forager-horticulturalists of Bolivia

R01-AR0730191 Oct 2026api.crossref.org

Macroscopic to ultrastructural analyses identify the loss of myofibrils as the primary mediator of ageing- and disuse-induced muscle fibre atrophy

AR082816, AR057347, AR08593925 Sept 2026pubmed.ncbi.nlm.nih.gov

Evaluation of exogenous estrogen use in patients with lobular neoplasia and its role in subsequent breast cancer development

K12AR0842273 Sept 2026api.crossref.org

Cardiovascular health and depression among postpartum women in the United States

K12AR08421918 Jul 2026api.crossref.org